|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-1-18
|
|
pubmed:abstractText |
Oral leukoplakia (OPL) is a heterogeneous oral lesion with an increased oral cancer risk. Current clinical parameters cannot predict the potential of malignant transformation in patients with OPL. We have shown that podoplanin, a lymphatic endothelial marker, is highly expressed in oral cancer and some oral premalignancies. The purpose of this study is to determine a role of podoplanin in predicting oral cancer development in patients with OPL.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:DeysSS,
pubmed-author:El-NaggarAdel KAK,
pubmed-author:FanYou-HongYH,
pubmed-author:HongWaun KiWK,
pubmed-author:KawaguchiHidetoshiH,
pubmed-author:KimEdwardE,
pubmed-author:LeeJ JackJJ,
pubmed-author:LippmanScott MSM,
pubmed-author:MaoLiL,
pubmed-author:PapadimitrakopoulouValiV,
pubmed-author:RenHeningH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
354-60
|
|
pubmed:meshHeading |
pubmed-meshheading:18202409-Adult,
pubmed-meshheading:18202409-Aged,
pubmed-meshheading:18202409-Aged, 80 and over,
pubmed-meshheading:18202409-Carcinoma, Squamous Cell,
pubmed-meshheading:18202409-Female,
pubmed-meshheading:18202409-Humans,
pubmed-meshheading:18202409-Hyperplasia,
pubmed-meshheading:18202409-Immunoenzyme Techniques,
pubmed-meshheading:18202409-Male,
pubmed-meshheading:18202409-Membrane Glycoproteins,
pubmed-meshheading:18202409-Middle Aged,
pubmed-meshheading:18202409-Mouth Neoplasms,
pubmed-meshheading:18202409-Neoplasm Staging,
pubmed-meshheading:18202409-Precancerous Conditions,
pubmed-meshheading:18202409-Prognosis,
pubmed-meshheading:18202409-Prospective Studies,
pubmed-meshheading:18202409-Tumor Markers, Biological,
pubmed-meshheading:18202409-Up-Regulation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
|
|
pubmed:affiliation |
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
